BRUKER CORPORATION Interest Expense Nonoperating
BRUKER CORPORATION (BRKR) reported Interest Expense Nonoperating of $17.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-05
- BRUKER CORPORATION interest expense nonoperating for the quarter ending 2026-06-30 was $17.80M, a 13.38% increase year-over-year.
- BRUKER CORPORATION interest expense nonoperating for the quarter ending 2026-03-31 was $12.20M, a 6.87% decline year-over-year.
- BRUKER CORPORATION interest expense nonoperating for the quarter ending 2025-12-31 was $11.20M, a 28.21% decline year-over-year.
- BRUKER CORPORATION interest expense nonoperating for the quarter ending 2025-09-30 was $20.30M, a 75.00% increase year-over-year.
- BRUKER CORPORATION interest expense nonoperating for fiscal 2025 was $60.30M, a 25.89% increase from fiscal 2024.
- BRUKER CORPORATION interest expense nonoperating for fiscal 2024 was $47.90M, a 192.07% increase from fiscal 2023.
- BRUKER CORPORATION interest expense nonoperating for fiscal 2023 was $16.40M, a 1.86% increase from fiscal 2022.
- BRUKER CORPORATION interest expense nonoperating for fiscal 2022 was $16.10M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.80M 10-Q · filed 2026-08-05 | $30.00M 10-Q · filed 2026-08-05 | $41.20M derived: sum of 3 quarters · filed 2026-08-05 | $61.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $12.20M 10-Q · filed 2026-05-07 | $23.40M derived: sum of 2 quarters · filed 2026-05-07 | $43.70M derived: sum of 3 quarters · filed 2026-05-07 | $59.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $31.50M derived: sum of 2 quarters · filed 2026-02-27 | $47.20M derived: sum of 3 quarters · filed 2026-08-05 | $60.30M 10-K · filed 2026-02-27 |
| 2025-09-30 | $20.30M 10-Q · filed 2025-11-05 | $36.00M derived: sum of 2 quarters · filed 2026-08-05 | $49.10M 10-Q · filed 2025-11-05 | $64.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $15.70M 10-Q · filed 2026-08-05 | $28.80M 10-Q · filed 2026-08-05 | $44.40M derived: sum of 3 quarters · filed 2026-08-05 | $56.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $13.10M 10-Q · filed 2026-05-07 | $28.70M derived: sum of 2 quarters · filed 2026-05-07 | $40.30M derived: sum of 3 quarters · filed 2026-05-07 | $56.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $15.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $27.20M derived: sum of 2 quarters · filed 2026-02-27 | $42.90M derived: sum of 3 quarters · filed 2026-02-27 | $47.90M 10-K · filed 2026-02-27 |
| 2024-09-30 | $11.60M 10-Q · filed 2025-11-05 | $27.30M derived: sum of 2 quarters · filed 2025-11-05 | $32.30M 10-Q · filed 2025-11-05 | $36.70M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $15.70M 10-Q · filed 2025-08-06 | $20.70M 10-Q · filed 2025-08-06 | $25.10M derived: sum of 3 quarters · filed 2026-02-27 | $29.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $5.00M 10-Q · filed 2025-05-07 | $9.40M derived: sum of 2 quarters · filed 2026-02-27 | $13.30M derived: sum of 3 quarters · filed 2026-02-27 | |
| 2023-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.30M derived: sum of 2 quarters · filed 2026-02-27 | $16.40M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $3.90M 10-Q · filed 2024-11-07 | $12.00M 10-Q · filed 2024-11-07 | ||
| 2022-12-31 | $16.10M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |